These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

574 related articles for article (PubMed ID: 16816392)

  • 1. Determinants of diagnostic investigation sensitivities across the clinical spectrum of sporadic Creutzfeldt-Jakob disease.
    Collins SJ; Sanchez-Juan P; Masters CL; Klug GM; van Duijn C; Poleggi A; Pocchiari M; Almonti S; Cuadrado-Corrales N; de Pedro-Cuesta J; Budka H; Gelpi E; Glatzel M; Tolnay M; Hewer E; Zerr I; Heinemann U; Kretszchmar HA; Jansen GH; Olsen E; Mitrova E; Alpérovitch A; Brandel JP; Mackenzie J; Murray K; Will RG
    Brain; 2006 Sep; 129(Pt 9):2278-87. PubMed ID: 16816392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classification of sporadic Creutzfeldt-Jakob disease revisited.
    Cali I; Castellani R; Yuan J; Al-Shekhlee A; Cohen ML; Xiao X; Moleres FJ; Parchi P; Zou WQ; Gambetti P
    Brain; 2006 Sep; 129(Pt 9):2266-77. PubMed ID: 16923954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants.
    Zerr I; Schulz-Schaeffer WJ; Giese A; Bodemer M; Schröter A; Henkel K; Tschampa HJ; Windl O; Pfahlberg A; Steinhoff BJ; Gefeller O; Kretzschmar HA; Poser S
    Ann Neurol; 2000 Sep; 48(3):323-9. PubMed ID: 10976638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MRI lesion profiles in sporadic Creutzfeldt-Jakob disease.
    Meissner B; Kallenberg K; Sanchez-Juan P; Collie D; Summers DM; Almonti S; Collins SJ; Smith P; Cras P; Jansen GH; Brandel JP; Coulthart MB; Roberts H; Van Everbroeck B; Galanaud D; Mellina V; Will RG; Zerr I
    Neurology; 2009 Jun; 72(23):1994-2001. PubMed ID: 19506221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD.
    Krasnianski A; Schulz-Schaeffer WJ; Kallenberg K; Meissner B; Collie DA; Roeber S; Bartl M; Heinemann U; Varges D; Kretzschmar HA; Zerr I
    Brain; 2006 Sep; 129(Pt 9):2288-96. PubMed ID: 16720682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Defining the phenotypic spectrum of sporadic Creutzfeldt-Jakob disease MV2K: the kuru plaque type.
    Baiardi S; Mammana A; Dellavalle S; Rossi M; Redaelli V; Colaizzo E; Di Fede G; Ladogana A; Capellari S; Parchi P
    Brain; 2023 Aug; 146(8):3289-3300. PubMed ID: 36883639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14-3-3 CSF levels in sporadic Creutzfeldt-Jakob disease differ across molecular subtypes.
    Gmitterová K; Heinemann U; Bodemer M; Krasnianski A; Meissner B; Kretzschmar HA; Zerr I
    Neurobiol Aging; 2009 Nov; 30(11):1842-50. PubMed ID: 18328602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sporadic Creutzfeldt-Jakob Disease MM1+2C and MM1 are Identical in Transmission Properties.
    Kobayashi A; Matsuura Y; Iwaki T; Iwasaki Y; Yoshida M; Takahashi H; Murayama S; Takao M; Kato S; Yamada M; Mohri S; Kitamoto T
    Brain Pathol; 2016 Jan; 26(1):95-101. PubMed ID: 25851836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sensitivity of 14-3-3 protein test varies in subtypes of sporadic Creutzfeldt-Jakob disease.
    Castellani RJ; Colucci M; Xie Z; Zou W; Li C; Parchi P; Capellari S; Pastore M; Rahbar MH; Chen SG; Gambetti P
    Neurology; 2004 Aug; 63(3):436-42. PubMed ID: 15304573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prions from Sporadic Creutzfeldt-Jakob Disease Patients Propagate as Strain Mixtures.
    Cassard H; Huor A; Espinosa JC; Douet JY; Lugan S; Aron N; Vilette D; Delisle MB; Marín-Moreno A; Peran P; Beringue V; Torres JM; Ironside JW; Andreoletti O
    mBio; 2020 Jun; 11(3):. PubMed ID: 32546613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical characteristics and laboratory findings in prion diseases].
    Shiga Y
    Nihon Rinsho; 2007 Aug; 65(8):1407-15. PubMed ID: 17695277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical diagnosis of MM2-type sporadic Creutzfeldt-Jakob disease.
    Hamaguchi T; Kitamoto T; Sato T; Mizusawa H; Nakamura Y; Noguchi M; Furukawa Y; Ishida C; Kuji I; Mitani K; Murayama S; Kohriyama T; Katayama S; Yamashita M; Yamamoto T; Udaka F; Kawakami A; Ihara Y; Nishinaka T; Kuroda S; Suzuki N; Shiga Y; Arai H; Maruyama M; Yamada M
    Neurology; 2005 Feb; 64(4):643-8. PubMed ID: 15728285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel PRNP mutation in a patient with a slow progressive dementia syndrome.
    Heinemann U; Krasnianski A; Meissner B; Grasbon-Frodl EM; Kretzschmar HA; Zerr I
    Med Sci Monit; 2008 May; 14(5):CS41-43. PubMed ID: 18443555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular basis of phenotypic variability in sporadic Creutzfeldt-Jakob disease.
    Parchi P; Castellani R; Capellari S; Ghetti B; Young K; Chen SG; Farlow M; Dickson DW; Sima AA; Trojanowski JQ; Petersen RB; Gambetti P
    Ann Neurol; 1996 Jun; 39(6):767-78. PubMed ID: 8651649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical range and MRI in Creutzfeldt-Jakob disease with heterozygosity at codon 129 and prion protein type 2.
    Samman I; Schulz-Schaeffer WJ; Wöhrle JC; Sommer A; Kretzschmar HA; Hennerici M
    J Neurol Neurosurg Psychiatry; 1999 Nov; 67(5):678-81. PubMed ID: 10519881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prion-specific and surrogate CSF biomarkers in Creutzfeldt-Jakob disease: diagnostic accuracy in relation to molecular subtypes and analysis of neuropathological correlates of p-tau and Aβ42 levels.
    Lattanzio F; Abu-Rumeileh S; Franceschini A; Kai H; Amore G; Poggiolini I; Rossi M; Baiardi S; McGuire L; Ladogana A; Pocchiari M; Green A; Capellari S; Parchi P
    Acta Neuropathol; 2017 Apr; 133(4):559-578. PubMed ID: 28205010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008.
    Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL
    Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular subtype-specific clinical diagnosis of prion diseases.
    Heinemann U; Krasnianski A; Meissner B; Gloeckner SF; Kretzschmar HA; Zerr I
    Vet Microbiol; 2007 Aug; 123(4):328-35. PubMed ID: 17513070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel prion protein gene mutation at codon 196 (E196A) in a septuagenarian with Creutzfeldt-Jakob disease.
    Zhang H; Wang M; Wu L; Zhang H; Jin T; Wu J; Sun L
    J Clin Neurosci; 2014 Jan; 21(1):175-8. PubMed ID: 23787189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features and diagnosis of the MM2 cortical subtype of sporadic Creutzfeldt-Jakob disease.
    Krasnianski A; Meissner B; Schulz-Schaeffer W; Kallenberg K; Bartl M; Heinemann U; Varges D; Kretzschmar HA; Zerr I
    Arch Neurol; 2006 Jun; 63(6):876-80. PubMed ID: 16769870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.